Correlation Between Zivo Bioscience and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zivo Bioscience and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zivo Bioscience and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zivo Bioscience and Akari Therapeutics PLC, you can compare the effects of market volatilities on Zivo Bioscience and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zivo Bioscience with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zivo Bioscience and Akari Therapeutics.
Diversification Opportunities for Zivo Bioscience and Akari Therapeutics
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Zivo and Akari is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Zivo Bioscience and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Zivo Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zivo Bioscience are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Zivo Bioscience i.e., Zivo Bioscience and Akari Therapeutics go up and down completely randomly.
Pair Corralation between Zivo Bioscience and Akari Therapeutics
Given the investment horizon of 90 days Zivo Bioscience is expected to generate 0.84 times more return on investment than Akari Therapeutics. However, Zivo Bioscience is 1.2 times less risky than Akari Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about -0.03 per unit of risk. If you would invest 289.00 in Zivo Bioscience on September 4, 2024 and sell it today you would lose (108.00) from holding Zivo Bioscience or give up 37.37% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 30.77% |
Values | Daily Returns |
Zivo Bioscience vs. Akari Therapeutics PLC
Performance |
Timeline |
Zivo Bioscience |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Akari Therapeutics PLC |
Zivo Bioscience and Akari Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zivo Bioscience and Akari Therapeutics
The main advantage of trading using opposite Zivo Bioscience and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zivo Bioscience position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.Zivo Bioscience vs. RenovoRx | Zivo Bioscience vs. Pasithea Therapeutics Corp | Zivo Bioscience vs. Quoin Pharmaceuticals Ltd | Zivo Bioscience vs. Erasca Inc |
Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |